Medications for Cardiovascular Diseases

4 results

  • crestor - rosuvastatin tablet, film coated

    (Rosuvastatin)
    Astrazeneca Pharmaceuticals Lp
    Crestor lowers LDL cholesterol and reduces major cardiovascular event risk in high-risk adults. Also indicated for primary hyperlipidemia, slowing atherosclerosis, familial hypercholesterolemia (HeFH in adults/children ≥8; HoFH in adults/children ≥7), primary dysbetalipoproteinemia, and hypertriglyceridemia.
    Medication Details
    Drug Interactions

  • glyxambi - empagliflozin and linagliptin tablet, film coated

    (Empagliflozin And Linagliptin)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    GLYXAMBI (empagliflozin/linagliptin) is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes. Empagliflozin also reduces the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.
    Medication Details
    Drug Interactions

  • synjardy - empagliflozin and metformin hydrochloride tablet

    (Empagliflozin And Metformin Hydrochloride)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    Synjardy (empagliflozin/metformin) is indicated with diet and exercise to improve blood sugar control in adults and children 10+ with type 2 diabetes. The empagliflozin component also reduces risk of cardiovascular death, heart failure hospitalization, and kidney disease progression in adults with established cardiovascular disease, heart failure, or chronic kidney disease.
    Medication Details
    Drug Interactions

  • victoza - liraglutide injection

    (Liraglutide)
    Novo Nordisk
    Victoza treats type 2 diabetes in adults and children aged 10+ as an adjunct to diet and exercise. It also reduces the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) in adults with type 2 diabetes and established cardiovascular disease.
    Medication Details
    Drug Interactions